Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL29570469 | 0.96 | ALDH1A1 (0.33) | ALDH1A1TSHRKMT2AALOX12MEN1 | |
| Ethyl Acetate SCHEMBL30954647 | 0.89 | ALDH1A1 (0.47) | ALDH1A1TSHRKMT2AALOX12MEN1 | |
| SCHEMBL30517388 | 0.86 | ALDH1A1 (0.32) | ALDH1A1TSHRKMT2AALOX12MEN1 | |
| SCHEMBL30577532 | 0.85 | ALDH1A1 (0.41) | ALDH1A1TSHRKMT2AALOX12MEN1 | |
| SCHEMBL10874557 | 0.84 | PPARG (0.31) | — | |
| SCHEMBL13748906 | 0.82 | KMT2A (0.35) | ALDH1A1TSHRKMT2AALOX12MEN1 | |
| SCHEMBL8570905 | 0.82 | CYP2C9 (0.44) | ALDH1A1TSHRKMT2AALOX12MEN1 | |
| SCHEMBL8570901 | 0.82 | CYP2C9 (0.44) | ALDH1A1TSHRKMT2AALOX12MEN1 | |
| SCHEMBL11786885 | 0.82 | CYP2C9 (0.44) | ALDH1A1TSHRKMT2AALOX12MEN1 | |
| SCHEMBL14877356 | 0.81 | ESR1 (0.37) | ALDH1A1TSHRKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12319660-B2 | Preparation of substituted diaminopyrazine dicarboxylic acids | MEDIBEACON INC. (US) | 2025-06-03 | — | — | US | claimed |
| US-20250109170-A1 | METHOD FOR MANUFACTURING GANIRELIX | ANYGEN CO., LTD. (KR) | 2025-04-03 | — | — | US | claimed |
| EP-4313172-A1 | PREPARATION OF SUBSTITUTED DIAMINOPYRAZINE DICARBOXYLIC ACIDS | Medibeacon Inc. (US) | 2024-02-07 | — | — | EP | claimed |
| CN-114945580-B | Method for synthesizing south Ji Botai | 北京费森尤斯卡比医药有限公司 | 2023-12-15 | — | — | CN | claimed |
| EP-4201951-B1 | METHOD FOR PEPTIDE SYNTHESIS | BACHEM HOLDING AG (CH) | 2023-11-22 | — | — | EP | claimed |
| WO-2023101490-A1 | NOVEL METHOD FOR MANUFACTURING GANIRELIX | 애니젠 주식회사 | 2023-06-08 | — | — | WO | claimed |
| US-20220324818-A1 | PREPARATION OF SUBSTITUTED DIAMINOPYRAZINE DICARBOXYLIC ACIDS | MEDIBEACON INC. | 2022-10-13 | — | — | US | claimed |
| CN-114945580-A | Method for synthesizing Nanjibor peptide | 北京费森尤斯卡比医药有限公司 | 2022-08-26 | — | — | CN | claimed |
| EP-3450439-B1 | METHOD FOR PRODUCING MONOMER FOR SINGLE-STRANDED NUCLEIC ACID MOLECULE | SUMITOMO CHEMICAL CO (JP) | 2021-01-20 | — | — | EP | claimed |
| EP-3110828-B1 | CONTINUOUS FLOW PEPTIDE SYNTHESIS | UNIV SZEGEDI (HU) | 2020-12-09 | — | — | EP | claimed |
| WO-2019005796-A1 | PROCESS FOR THE PREPARATION OF PYRAZOLO[1,5-a]PYRIMIDINES AND SALTS THEREOF | ZHAO QIAN (US) | 2019-01-03 | — | — | WO | claimed |
| WO-2018081417-A2 | PROCESS FOR THE PREPARATION OF PYRAZOLO[1,5-a]PYRIMIDINES AND SALTS THEREOF | ZHAO QIAN (US) | 2018-05-03 | — | — | WO | claimed |
| EP-3110828-A1 | CONTINUOUS FLOW PEPTIDE SYNTHESIS | Szegedi Tudományegyetem (HU) | 2017-01-04 | — | — | EP | claimed |
| EP-2694531-B1 | METHODS FOR MANUFACTURING AN ANTIFUNGAL AGENT | XELLIA PHARMACEUTICALS APS (DK) | 2016-09-14 | — | — | EP | claimed |
| WO-2015128687-A1 | CONTINUOUS FLOW PEPTIDE SYNTHESIS | Szegedi Tudományegyetem (HU) | 2015-09-03 | — | — | WO | claimed |
| US-8981055-B2 | Methods for manufacturing an antifungal agent | XELLIA PHARMACEUTICALS APS (DK) | 2015-03-17 | — | — | US | claimed |
| US-20140371422-A1 | METHODS FOR MANUFACTURING AN ANTIFUNGAL AGENT | XELLIA PHARMACEUTICALS APS (DK) | 2014-12-18 | — | — | US | claimed |
| EP-2694531-A1 | METHODS FOR MANUFACTURING AN ANTIFUNGAL AGENT | Xellia Pharmaceuticals ApS (DK) | 2014-02-12 | — | — | EP | claimed |
| WO-2012136498-A1 | METHODS FOR MANUFACTURING AN ANTIFUNGAL AGENT | XELLIA PHARMACEUTICALS APS (DK) | 2012-10-11 | — | — | WO | claimed |
| US-20070114155-A1 | Hydrotreating and/or hydrocracking catalyst of hydrocarbons and preparation thereof | TOTAL RAFFINAGE FRANCE (FR) | 2007-05-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12319660-B2 | Preparation of substituted diaminopyrazine dicarboxylic acids | DDC, DPYD, SDHA | ALDH1A1 205/4885TSHR 4451/4885KMT2A 1466/4885 |
| US-20140371422-A1 | METHODS FOR MANUFACTURING AN ANTIFUNGAL AGENT | DPM1, ERG28, MANBA | ALDH1A1 2575/4885TSHR 4661/4885KMT2A 3563/4885 |
| US-20220324818-A1 | PREPARATION OF SUBSTITUTED DIAMINOPYRAZINE DICARBOXYLIC ACIDS | DDC, DPYD, SDHA | ALDH1A1 205/4885TSHR 4451/4885KMT2A 1466/4885 |
| US-20250109170-A1 | METHOD FOR MANUFACTURING GANIRELIX | VIP, GLP1R, CCKBR | ALDH1A1 3518/4885TSHR 1257/4885KMT2A 4309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.